Investor insights
Sectors invested in
Research1
Medical1
Health Care1
Crohn's Disease1
Advocacy1
Ulcerative Colitis1
Inflammatory Bowel Disease1
Patient Services1
Volunteering1
Health1
Funding rounds participated in
$1M sweet spot round size
Most of their 1 investments are in rounds between $1M and $1M
Basic info
Industry
pharmaceutical manufacturing
Sectors
Pharmaceutical
Neuroscience
Oncologie
Gastroenterology
Maladies rares
Gastroentérologie
Rare Disease
Health Care
Neurosciences
Oncology
Date founded
1781
Investments made
C
Crohn's and Colitis Canada raised $1M on February 3, 2022
Investors: Takeda Canada Inc.